Trombocitopenia imune
Última atualização 18 de ago de 2020
Atende aos diretrizes editoriais
- BaixarBaixar
- Compartilhar
- Language
- Discussão
- Ask Patient
- Versão em Áudio
- Adicionar às fontes preferidas no Google
Immune thrombocytopenia is a disorder characterised by a blood abnormality called thrombocytopenia, which is a shortage of blood cells called platelets that are needed for normal blood clotting.
Escolhas de vídeos para Condições genéticasBiblioteca de vídeos
Descrição
Immune thrombocytopenia is a disorder characterised by a blood abnormality called thrombocytopenia, which is a shortage of blood cells called platelets that are needed for normal blood clotting.
Affected individuals can develop red or purple spots on the skin caused by bleeding just under the skin's surface. Small spots of bleeding under the skin are called purpura and larger spots are called ecchymoses. People with immune thrombocytopenia can have significant bleeding episodes, such as nose bleeds (epistaxis) or bleeding in the moist lining (mucosae) of the mouth. In severe cases, individuals may have gastrointestinal bleeding or blood in the urine or stool, or heavy and prolonged menstrual bleeding (menorrhagia). In very rare instances, bleeding inside the skull (intracranial hemorrhage) can occur, which can be life-threatening. A greater reduction in platelet numbers is often associated with more frequent bleeding episodes and an increased risk of severe bleeding.
While immune thrombocytopenia can be diagnosed at any age, there are two periods when the condition is most likely to develop: early childhood and late adulthood. In children, the reduction in platelets is often sudden, but platelet levels usually return to normal levels within weeks to months. Immune thrombocytopenia in children is often preceded by a minor infection, such as an upper respiratory infection, but the relationship between the infection and immune thrombocytopenia is not clear. In adults, the development of immune thrombocytopenia is usually gradual and the condition tends to persist throughout life.
Padrões de herança
The source lists the following possible inheritance patterns: Pattern unknown. More than one pattern can apply in different cases.
Other names
Autoimmune thrombocytopenia
Autoimmune thrombocytopenic purpura
Idiopathic thrombocytopenic purpura
Púrpura trombocitopênica imune
ITP
Werlhof disease
Related patient information and medicines

Patient information leaflet
Púrpura trombocitopênica imune
In immune thrombocytopenic purpura, antibodies are made against platelets. Once the ant... What is immune thrombocytopenic purpura. Immune thrombocytopenic purpura (ITP) is an autoimmune disorder. In autoimmune disorders your body makes proteins called antibodies which damage another part of your body. It is called ' immune ' because it is now.

Patient information leaflet
Hemograma completo e esfregaço de sangue
Leukaemia Leukaemia is a type of blood cancer where there is a large number of abnormal cells, usually white blood cells. The type of leukaemia depends on the type of white cell affected. Too few platelets - this is called thrombocytopenia Immune thrombocytopenic purpura. This may make you bruise or bleed easily. There are various causes. Too many.

Patient information leaflet
Púrpura
Because there are so many causes for purpura, diagnosing the reason why you have developed a purpuric rash takes a bit of detective work. What is purpura. Purpura just means purple. Cancer deposits replacing the bone marrow. Medicines such as co-trimoxazole (an antibiotic) and chemicals. Conditions that increase the breakdown of platelets, such.

Patient information leaflet
Imunossupressão
Immune suppression describes a loss of immune function. What is immunosuppression. The spleen is an important part of your immune system but sometimes it needs to be removed with an operation called a splenectomy. Examples where this occurs and the spleen may need to be removed incluir: Immune thrombocytopenia. Immune thrombocytopenic purpura.

Patient information leaflet
Testes de coagulação do sangue
Testes de coagulação do sangue are used to diagnose and assess bleeding problems and to monitor people who take warfarin or other anticoagulant medicines. You may be advised to have blood clotting tests: If you have a suspected bleeding disorder. ... Bleeding disorders There are various conditions where you tend to bleed excessively if you damage or cut a.

Patient information leaflet
Síndrome do anticorpo antifosfolipídico
Síndrome do anticorpo antifosfolipídico is sometimes called Hughes' syndrome. It is a disease that affects the blood and makes it more likely to clot than normal - a thrombophilia. What is antiphospholipid syndrome. Antiphospholipid syndrome (APS) - also called Hughes' syndrome - makes blood more likely than normal to clot (a thrombophilia Thrombophilia ). This.
Leitura adicional e referências
- Trombocitopenia imune; MedlinePlus, National Library of Medicine.
- Alam MM. Idiopathic thrombocytopenic purpura in children: a 10 years experience at tertiary care hospital. J Pak Med Assoc. 2014 Dec;64(12):1358-62.
- Arnold DM. Bleeding complications in immune thrombocytopenia. Hematology Am Soc Hematol Educ Program. 2015;2015:237-42. doi: 10.1182/asheducation-2015.1.237.
- Doobaree IU, Nandigam R, Bennett D, Newland A, Provan D. Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis. Eur J Haematol. 2016 Oct;97(4):321-30. doi: 10.1111/ejh.12777. Epub 2016 Jun 20.
- Neunert C, Noroozi N, Norman G, Buchanan GR, Goy J, Nazi I, Kelton JG, Arnold DM. Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. J Thromb Haemost. 2015 Mar;13(3):457-64. doi: 10.1111/jth.12813. Epub 2015 Jan 14.
- Ozkan MC, Sahin F, Saydam G. Immune thrombocytopenic purpura: new biological therapy of an old disease. Curr Med Chem. 2015;22(16):1956-62. doi: 10.2174/0929867322666150319102830.
- Provan D, Newland AC. Current Management of Primary Immune Thrombocytopenia. Adv Ther. 2015 Oct;32(10):875-87. doi: 10.1007/s12325-015-0251-z. Epub 2015 Oct 26.
- Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010 Jan 14;115(2):168-86. doi: 10.1182/blood-2009-06-225565. Epub 2009 Oct 21.
- Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kuhne T, Ruggeri M, George JN. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009 Mar 12;113(11):2386-93. doi: 10.1182/blood-2008-07-162503. Epub 2008 Nov 12.
- Smalisz-Skrzypczyk K, Romiszewski M, Matysiak M, Demkow U, Pawelec K. The Influence of Primary Cytomegalovirus or Epstein-Barr Virus Infection on the Course of Idiopathic Thrombocytopenic Purpura. Adv Exp Med Biol. 2016;878:83-8. doi: 10.1007/5584_2015_162.
Compartilhe seus pensamentos ou experiências com outros em nosso comunidades de pacientes.
Inscreva-se no boletim informativo do Patient
Sua dose semanal de conselhos de saúde claros e confiáveis - escritos para ajudá-lo a se sentir informado, confiante e no controle.
Ao se inscrever, você aceita nossos Política de Privacidade. Você pode cancelar a inscrição a qualquer momento. Nunca vendemos seus dados.

